The U.S. Court of Appeals for the Second Circuit pushed back next month’s oral arguments to Nov. 17 in the multidistrict litigation over acetaminophen after both sides submitted letters discussing Monday’s announcement from President Donald Trump linking Tylenol to autism.
The U.S. Court of Appeals for the Second Circuit pushed back next month’s oral arguments to Nov. 17 in the multidistrict litigation over acetaminophen after both sides submitted letters discussing Monday’s announcement from President Donald Trump linking Tylenol to autism.
